Cardiogenic Shock,, With APACH II Score >25), With ECMO or IABP Support,
Conditions
Keywords
ECMO, APACH II score
Brief summary
The study is to show the prognostic factor of HRV parameter and cardiac fibrosis markers in critical illness patients
Detailed description
The analysis of Heart Rate Variability with 24hrs Holter ECG and serum cardiac fibrosis markers in critical illness patients who are with cardiogenic shock, with ECMO or IABP support, or with APACH II score \>25)
Interventions
None listed
Sponsors
National Taiwan University Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* critical illness patients who are with cardiogenic shock, with ECMO or IABP support, or with APACH II score \>25)
Exclusion criteria
* pacemaker rhythm, not sign the permit
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Heart Rate Variability and serum cardiac fibrosis markers in critical illness patients | 2-4weeks | 1. Outcome measurement: The measure is a composite outcome measure consisting of multiple measures (results to be reported as a single value for each Arm/Group), no changes are required 2. List the primary condition or disease being studied Shock needing ECMO support |
Countries
Taiwan
Outcome results
None listed